| __timestamp | Biogen Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 241751000 |
| Thursday, January 1, 2015 | 2012800000 | 322292000 |
| Friday, January 1, 2016 | 1973300000 | 344320000 |
| Sunday, January 1, 2017 | 2253600000 | 374644000 |
| Monday, January 1, 2018 | 2597200000 | 414604000 |
| Tuesday, January 1, 2019 | 2280600000 | 466000000 |
| Wednesday, January 1, 2020 | 3990900000 | 535000000 |
| Friday, January 1, 2021 | 2501200000 | 643000000 |
| Saturday, January 1, 2022 | 2231100000 | 833000000 |
| Sunday, January 1, 2023 | 2702600000 | 899625000 |
| Monday, January 1, 2024 | 2041800000 | 901530000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal. Over the past decade, Biogen Inc. and Ionis Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D expenditures. Biogen, a leader in neurological therapies, has consistently invested heavily, with a peak in 2020 where their R&D expenses surged by over 100% compared to 2014. This reflects their commitment to pioneering treatments in a competitive market.
Conversely, Ionis Pharmaceuticals, known for its RNA-targeted therapeutics, has shown a steady increase in R&D spending, growing by approximately 270% from 2014 to 2023. This gradual rise underscores their strategic focus on innovation and long-term growth. As of 2023, Ionis's R&D investment reached nearly 900 million, marking a significant milestone in their journey.
These trends highlight the dynamic nature of biotech investments, where strategic R&D spending can shape the future of healthcare.
R&D Insights: How Johnson & Johnson and Ionis Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Biogen Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Corcept Therapeutics Incorporated
Biogen Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Biogen Inc. or MorphoSys AG: Who Invests More in Innovation?
Biogen Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and MannKind Corporation
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation